Advertisement

Topics

Latest "SC Johnson" News Stories

13:30 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "SC Johnson" found in our extensive news archives from over 250 global news sources.

More Information about SC Johnson on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SC Johnson for you to read. Along with our medical data and news we also list SC Johnson Clinical Trials, which are updated daily. BioPortfolio also has a large database of SC Johnson Companies for you to search.

Showing "Johnson" News Articles 1–25 of 1,200+

Saturday 15th December 2018

Biosense Webster Inc Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryBiosense Webster Inc Biosense Webster, a subsidiary of Johnson Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company's products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac mapping. It offers fibrillation, ventricular tachycardia, atrial flutter, simple arrhythmias and fluoro...


A Mount Sinai scientist told Johnson & Johnson he found small amounts of asbestos in its Baby Powder in 1971. J&J disagreed and put his name on an internal list of ‘antagonistic personalities’ https://reut.rs/2RZJGz3 pic.twitter.com/UVbgYrsrlm

A Mount Sinai scientist told Johnson & Johnson he found small amounts of asbestos in its Baby Powder in 1971. J&J disagreed and put his name on an internal list of ‘antagonistic personalities’ https://reut.rs/2RZJGz3  pic.twitter.com/UVbgYrsrlm

Wie Johnson & Johnson, Walgreens Boots Alliance, Cisco ...

Das hat die BSNgine heute ausgewiesen.JNJ: Johnson & Johnson am 14.12. -10,04%, Volumen 841% normaler Tage , WBA: Walgreens Boots Alliance am 14.12. -4,35%, Volumen 142% normaler Tage , CIS: Cisco ...


Friday 14th December 2018

In Battle Over Johnson’s Baby Powder, Asbestos Opens a New Legal Front

Johnson & Johnson says its product is safe. But asbestos, a carcinogen that can exist underground near talc, was a concern inside the company for decades.

Should Investors Worry About The Latest In Johnson & Johnson's Talcum Case?

“Johnson & Johnson knew about asbestos in its baby powder for decades, report says” https://reut.rs/2S0PKr3 

“Johnson & Johnson knew about asbestos in its baby powder for decades, report says” https://reut.rs/2S0PKr3 

Hagens Berman Notifies Johnson Johnson (JNJ) Investors of the Firm's Investigation of Possible ...

SAN FRANCISCO, Dec. 14, 2018 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP notifies investors in Johnson & Johnson (NYSE: JNJ) of the Firm's investigation of Read more...

MÄRKTE USA/Wall Street im Korrekturmodus - Johnson & Johnson brechen ein

Von Thomas Rossmann NEW YORK (Dow Jones)--Zunehmende Sorgen um das weltweite Konjunkturwachstum haben an der Wall Street zum Wochenausklang für ein kräftiges Minus gesorgt. Mit schwachen Daten aus...

PDA Announces Diverse 2019 Board of Directors

PDA's 2019 Board of Directors is one of them of the most diverse boards in the pharmaceutical industry. BETHESDA, Md. (PRWEB) December 14, 2018 The Parenteral Drug Association (PDA) today announced the results of its Board of Directors Election for the term beginning January 1, 2019. In the fall of 2018, PDA’s 10,500 members had an opportunity to participate in the election of new directors...

Janssen Submits sNDA for Xarelto to Prevent Venous Thromboembolism in Acutely Ill Patients

NewsIf approved, it will add to Xarelto's five existing Venous Thromboembolism indications, including treatment of deep vein thrombosis and pulmonary embolism.

J&J shares nosedive on report company knew of asbestos in baby powder

Shares of Johnson & Johnson tumbled 12 percent on Friday and were on track to post their biggest percentage drop in more than 16 years, after Reuters reported that the pharma major knew for decades that cancer-causing asbestos lurked in its Baby Pow...

Johnson & Johnson Down 8% On Report Of Asbestos In Baby Powder

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) slipped a sharp 8% on Friday after a report from Reuters said the healthcare giant knew for decades that its baby powder contained asbes...

Johnson & Johnson-Aktie mit Bericht über Babypuder massiv unter Druck

NEW YORK (Dow Jones)--Die Aktie von Johnson & Johnson steht am Freitag an der Wall Street deutlich unter Druck und verzeichnet das stärkste Tagesminus seit März 2000. Hintergrund ist eine Reuters-...

J&J kept a guiding hand on talc safety research

Johnson & Johnson developed a strategy in the 1970s to deal with a growing volume of research showing that talc miners had elevated rates of lung disease and cancer: Promote the positive, challenge the negative.

J&J Posting Steep Loss On Reported Knowledge Of Asbestos In Baby Powder

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) have moved sharply lower over the course of the trading session on Friday, plunging by 9.6 percent. With the steep drop, J&J has fallen ...

MÄRKTE USA/Konjunktursorgen belasten - Johnson & Johnson brechen ein

Von Thomas Rossmann NEW YORK (Dow Jones)--Die Unsicherheit um das weltweite Konjunkturwachstum drückt zum Wochenausklang auf die Stimmung an der Wall Street. Mit schwachen Daten aus China seien be...

Johnson & Johnson shares sharply drop at the open after Reuters reports that the company knew for decades about asbestos in baby powder talc supply http://cnbc.com/id/105622829 pic.twitter.com/GF3DSCFHOB

Johnson & Johnson shares sharply drop at the open after Reuters reports that the company knew for decades about asbestos in baby powder talc supply http://cnbc.com/id/105622829  pic.twitter.com/GF3DSCFHOB

Darlene Coker knew she was dying. She just wanted to know why. @specialreports investigates Johnson & Johnson’s decades-long history of carcinogenic asbestos showing up in its talc https://reut.rs/2EvsBdl pic.twitter.com/PhP71yFoMJ

Darlene Coker knew she was dying. She just wanted to know why. @specialreports investigates Johnson & Johnson’s decades-long history of carcinogenic asbestos showing up in its talc https://reut.rs/2EvsBdl  pic.twitter.com/PhP71yFoMJ

J&J shares nosedive on report it knew of asbestos in Baby Powder

Shares of Johnson & Johnson fell 10 percent on Friday and were on track to post their biggest percentage drop in more than 16 years, after Reuters reported that the pharma major knew for decades that cancer-causing asbestos lurked in its Baby Powder...

Thursday 13th December 2018

Janssen reports positive results from plaque psoriasis trial

Janssen Pharmaceutical Companies of Johnson & Johnson has reported positive results from the Phase III ECLIPSE trial that investigated the...Read More... The post Janssen reports positive results from plaque psoriasis trial appeared first on Drug Development Technology.

New Phase 3 Data Demonstrate Superiority of Tremfya vs Cosentyx in Delivering PASI 90 Responses in Plaque Psoriasis

VIENNA–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the ECLIPSE study demonstrating that TREMFYA® (guselkumab) was superior to Cosentyx® (secukinumab)* in treating adults with moderate to severe plaque psoriasis for the primary endpoint assessed at week 48. Data from the multicentre, randomised, double-blind head-to-hea...

The American Board of Pathology and the American Society for Clinical Pathology Announce an Opportunity to Earn CME/SAM Credits for Participating in ABPath CertLink®

Innovative assessment program drives physician professional development CHICAGO (PRWEB) December 13, 2018 The American Board of Pathology (ABPath) and the American Society for Clinical Pathology (ASCP) are pleased to announce a partnership to award Continuing Medical Education (CME/SAM) credits to participants in ABPath CertLink®, an innovative assessment program that drives physician profes...

The Wild West Approach to PICUs

(MedPage Today) -- We need a formalized protocol, says Christopher Johnson, MD

Former California Deputy Attorney General and Special Prosecutor with Johnson Fistel Launches ...

SAN DIEGO, Dec. 13, 2018 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP with the assistance of former California Deputy Attorney General and Special Read more...

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

BiomX’s XMarker microbiome-based biomarker discovery platform to identify responders to a key Janssen IBD therapeutic Ness Ziona, Israel – Dec. 12, 2018 – BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has entered into a collaboration with Janssen Research & Development, LLC to utilize BiomX’s XMarker microbiome-based biomarker discovery...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks